Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Concert Pharmaceuticals, Inc. (CNCE)

« Back to company index

CNCE Chatter Timeline

Stock Ticker for CNCE

Most Active Tweeters for CNCE

UserTweets
@Tickeron 7
@gcassidy718 5
@ConsumerFeed 4
@StockNewsNow 3
@WeekHerald 3

Recent Tweets for CNCE

AmericanBanking @AmericanBanking
Concert Pharmaceuticals $CNCE Releases Earnings Results https://t.co/dcZElD5Bai #stocks
November 10th 2019, 6:11pm
Gambiste1 @Gambiste1
RT @gcassidy718: $CNCE what a Company 5.16 % change recently https://t.co/Xu4o0gwiDu
November 10th 2019, 5:11pm
gcassidy718 @gcassidy718
$CNCE what a Company 5.16 % change recently https://t.co/Xu4o0gwiDu
November 10th 2019, 5:11pm
ThisLincolnian @ThisLincolnian
Concert Pharmaceuticals $CNCE Given Buy Rating at Mizuho https://t.co/dF89q2ze17
November 10th 2019, 1:11pm
dispatchtribune @dispatchtribune
Concert Pharmaceuticals $CNCE Rating Reiterated by Mizuho https://t.co/qI3ow0H8nV
November 10th 2019, 1:11pm
WeekHerald @WeekHerald
Concert Pharmaceuticals $CNCE Trading Up 5.2% Following Better-Than-Expected Earnings https://t.co/Byk4LjQtcX
November 10th 2019, 2:11am
OlympiaReport @OlympiaReport
Concert Pharmaceuticals $CNCE Stock Price Up 5.2% After Strong Earnings https://t.co/DbneP4s2fh
November 10th 2019, 1:11am
WeekHerald @WeekHerald
Concert Pharmaceuticals $CNCE Trading Up 5.2% Following Better-Than-Expected Earnings https://t.co/ggJPwNMFDH
November 10th 2019, 1:11am
ConsumerFeed @ConsumerFeed
Concert Pharmaceuticals $CNCE Receives “Buy” Rating from Mizuho https://t.co/S0j4eiH7FT
November 10th 2019, 12:11am
gcassidy718 @gcassidy718
$CNCE What happened??? why the bounce?? 5.16 % change recently https://t.co/Xu4o0gwiDu
November 9th 2019, 3:11pm
chiragontwtr @chiragontwtr
@Jdalexander64 $cnce added once daily dosing into their amended patent claims recently. New patent grant is a given… https://t.co/3CuHhHkfCe
November 9th 2019, 8:11am
StockNewsWires @StockNewsWires
$CNCE: Concert Pharmaceuticals, Inc. (CNCE) Q3 2019 Earnings Call …: https://t.co/nItIhEHKLN
November 9th 2019, 3:11am
WatchlistN @WatchlistN
Concert Pharmaceuticals $CNCE Stock Price Up 5.2% on Earnings Beat https://t.co/P6AKEiQ12P
November 9th 2019, 2:11am
EnterpriseLeade @EnterpriseLeade
Concert Pharmaceuticals $CNCE Lowered to Sell at Zacks Investment Research https://t.co/hxSXjMhVhk
November 8th 2019, 9:11pm
TranscriptDaily @TranscriptDaily
Concert Pharmaceuticals $CNCE Lowered to Sell at Zacks Investment Research https://t.co/w7ns2YQvUw
November 8th 2019, 9:11pm
bbnsnews @bbnsnews
Concert Pharmaceuticals $CNCE Trading 5.2% Higher on Earnings Beat https://t.co/iOaRubc3Bl
November 8th 2019, 6:11pm
ConsumerFeed @ConsumerFeed
Concert Pharmaceuticals $CNCE Trading 5.2% Higher After Earnings Beat https://t.co/OV8o9lvNTi
November 8th 2019, 6:11pm
BlueBioNow @BlueBioNow
$CNCE might be worth taking a position when this bottoms 6.25 % change recently https://t.co/KN4ghoK37B
November 8th 2019, 12:11pm
AmericanBanking @AmericanBanking
Concert Pharmaceuticals $CNCE Given Buy Rating at Mizuho https://t.co/DWrN2lyzxH #stocks
November 8th 2019, 10:11am
SeekingAlpha @SeekingAlpha
$CNCE - Concert Pharmaceuticals (CNCE) Investor Presentation - Slideshow. Sign up for updates on Seeking Alpha!… https://t.co/RTt7c84KVE
November 8th 2019, 9:11am
OlympiaReport @OlympiaReport
Concert Pharmaceuticals’ $CNCE Buy Rating Reaffirmed at Mizuho https://t.co/Mgax5Ka0Yx
November 8th 2019, 8:11am
WeekHerald @WeekHerald
Concert Pharmaceuticals’ $CNCE Buy Rating Reaffirmed at Mizuho https://t.co/qaw4SmWpuR
November 8th 2019, 8:11am
Tickeron @Tickeron
$CNCE's 10-day Moving Average moved below its 50-day Moving Average on September 27, 2019. View odds for this and o… https://t.co/yKh8mYzHva
November 8th 2019, 3:11am
TickerReport @TickerReport
ValuEngine Downgrades Concert Pharmaceuticals $CNCE to Hold https://t.co/MApdmvsagr
November 7th 2019, 6:11pm
WatchlistN @WatchlistN
Concert Pharmaceuticals $CNCE Downgraded by ValuEngine https://t.co/lWSqCLWpv7
November 7th 2019, 6:11pm
BlueBioNow @BlueBioNow
$CNCE This one is getting bipolar : ) 3.36 % change recently https://t.co/KN4ghoK37B
November 7th 2019, 5:11pm
Jdalexander64 @Jdalexander64
LifeSci Capital: $CNCE Concert Announces Q3 2019 Earnings, Highlights Progress on CTP-543 and CTP-692 OUTPERFORM $1… https://t.co/yKfYrVpQvc
November 7th 2019, 3:11pm
StockNewsNow @StockNewsNow
$CNCE Concert Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Company Update https://t.co/LAqzP1jpJq
November 7th 2019, 2:11pm
StockTexts @StockTexts
$CNCE Concert Pharmaceuticals, Inc. SEC Filing: Form 10-Q https://t.co/Y7Yy4dXcqU
November 7th 2019, 7:11am
Gambiste1 @Gambiste1
RT @MarketCurrents: $CNCE - Concert Pharma EPS beats by $0.11 https://t.co/Cf53oA4btV
November 7th 2019, 7:11am
Stock_News_Now @Stock_News_Now
$CNCE: New SEC Filing for CNCE: Form 8-K (No. 0001367920-19-000056): https://t.co/8E4EdxlOkD
November 7th 2019, 7:11am
MarketCurrents @MarketCurrents
$CNCE - Concert Pharma EPS beats by $0.11 https://t.co/Cf53oA4btV
November 7th 2019, 7:11am
Tickeron @Tickeron
$CNCE's 10-day Moving Average crossed below its 50-day Moving Average on September 27, 2019. View odds for this and… https://t.co/cqIIHjm5qJ
November 7th 2019, 3:11am
StockNewsNow @StockNewsNow
$CNCE Concert Pharmaceuticals to Host KOL Webcast Event Focused on CTP-692 and Schizophrenia https://t.co/sIYjSdl7qH
November 6th 2019, 11:11am
DataTrials @DataTrials
$CNCE Phase 2 Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata…NCT038… https://t.co/GcWxnXySpd
November 6th 2019, 6:11am
Tickeron @Tickeron
$CNCE's 10-day Moving Average moved below its 50-day Moving Average on September 27, 2019. View odds for this and o… https://t.co/da88JY2hfz
November 6th 2019, 4:11am
ConsumerFeed @ConsumerFeed
Concert Pharmaceuticals $CNCE Lowered to “Hold” at ValuEngine https://t.co/ruWPsvxpT6
November 5th 2019, 10:11pm
ThisLincolnian @ThisLincolnian
Concert Pharmaceuticals $CNCE Lowered to “Hold” at ValuEngine https://t.co/yMCK3WvMpu
November 5th 2019, 10:11pm
ConsumerFeed @ConsumerFeed
Concert Pharmaceuticals $CNCE to Release Quarterly Earnings on Thursday https://t.co/TeDxy6dzD5
November 5th 2019, 3:11pm
chiragontwtr @chiragontwtr
@briansutcliffe1 Some twist. Late Oct $CNCE amended their claims instead of going for final grant of patent. Includ… https://t.co/kn9oZerN3J
November 5th 2019, 9:11am
BlueBioNow @BlueBioNow
$CNCE Wow. Printing money ???????????????? 4.33 % change recently https://t.co/KN4ghoK37B
November 4th 2019, 10:11am
Tickeron @Tickeron
$CNCE's 10-day Moving Average moved below its 50-day Moving Average on September 27, 2019. View odds for this and o… https://t.co/crdpxrAFNL
November 4th 2019, 2:11am
gcassidy718 @gcassidy718
$CNCE Enjoy the weekend everyone! Cheers! ???? 4.33 % change recently https://t.co/Xu4o0gwiDu
November 2nd 2019, 9:11pm
gcassidy718 @gcassidy718
$CNCE is on the move with significant price changes 3.21 % https://t.co/Xu4o0gwiDu
November 1st 2019, 8:11pm
briansutcliffe1 @briansutcliffe1
@chiragontwtr $cnce excellent connection. Still awaiting $CNCE to announce new granted patent. However this ruling… https://t.co/d0Q7ROkWSw
November 1st 2019, 2:11pm
chiragontwtr @chiragontwtr
Advantage $CNCE ? $INCY patent is too broad and tries to cover hundreds (if not thousands) of variations of ruxoli… https://t.co/TUFMjJxkAa
November 1st 2019, 12:11pm
AmericanBanking @AmericanBanking
Concert Pharmaceuticals $CNCE Set to Announce Quarterly Earnings on Thursday https://t.co/Z1VEd3EUyl #stocks
November 1st 2019, 12:11pm
TheMarketsDaily @TheMarketsDaily
Concert Pharmaceuticals $CNCE Set to Announce Quarterly Earnings on Thursday https://t.co/Tw2ZkkXRal
November 1st 2019, 12:11pm
StockNewsNow @StockNewsNow
$CNCE Concert Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 7, 2019 https://t.co/L2ijELU3vB
October 31st 2019, 11:10am
Tickeron @Tickeron
$CNCE in Downtrend: Stochastic indicator peaks and leaves overbought zone. View odds for this and other indicators:… https://t.co/LEcbUPwQaI
October 31st 2019, 4:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.